Skip to Content
MilliporeSigma
All Photos(6)

Documents

HPA044620

Sigma-Aldrich

Anti-GPD1 antibody produced in rabbit

enhanced validation

affinity isolated antibody, buffered aqueous glycerol solution

Synonym(s):

Anti-Glycerol-3-phosphate dehydrogenase 1 (soluble)

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
Human Protein Atlas Number:

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous glycerol solution

species reactivity

human

enhanced validation

orthogonal RNAseq
Learn more about Antibody Enhanced Validation

technique(s)

immunoblotting: 0.04-0.4 μg/mL
immunohistochemistry: 1:50-1:200

immunogen sequence

PNVVAVPDVVQAAEDADILIFVVPHQFIGKICDQLKGHLKANATGISLIK

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... GPD1(2819)

General description

Glycerol-3-phosphate dehydrogenase 1 (GPD1) is encoded by the gene mapped to human chromosome 12q13.12. The encoded protein is a member of NAD-dependent glycerol-3-phosphate dehydrogenase family. GPD1 is a cytoplasmic protein with NAD_Gly3P_dh_N and NAD_Gly3P_dh_C domains.

Immunogen

glycerol-3-phosphate dehydrogenase 1 (soluble) recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies® protocols and other useful information.
Glycerol-3-phosphate dehydrogenase 1(GPD1) has been used in western blot analysis.

Biochem/physiol Actions

Glycerol-3-phosphate dehydrogenase 1 (GPD1) facilitates the reversible conversion of dihydroxyacetone phosphate (DHAP) and reduced nicotine adenine dinucleotide(NADH) to glycerol-3-phosphate (G3P) and nicotinamide adenine dinucleotide (NAD+). GPD1 along with a mitochondrial enzyme, glycerol-3 phosphate dehydrogenase 2 (GPD2), plays an essential role in carrying reducing equivalents from the cytosol to the mitochondria.1It also stimulates growth under osmotic stress. Loss of gene function inhibits glycerol production, retard growth at all under anoxic conditions and strong osmosensitivity. Mutation in the gene is associated with the development of transient infantile hypertriglyceridemia, fatty Liver and hepatic fibrosis.

Features and Benefits

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Linkage

Corresponding Antigen APREST81141

Physical form

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1.
Basel-Vanagaite L
American Journal of Human Genetics, 90, 49-60 (2012)
A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia.
Joshi M
European Journal of Human Genetics, 22, 1229-1232 (2014)
The two isoenzymes for yeast NAD+-dependent glycerol 3-phosphate dehydrogenase encoded by GPD1 and GPD2 have distinct roles in osmoadaptation and redox regulation.
Ansell R
The Embo Journal, 16, 2179-2187 (1997)
Mugdha Joshi et al.
European journal of human genetics : EJHG, 22(10), 1229-1232 (2014-02-20)
The constellation of clinico-pathological and laboratory findings including massive hepatomegaly, steatosis, and marked hypertriglyceridemia in infancy is extremely rare. We describe a child who is presented with the above findings, and despite extensive diagnostic testing no cause could be identified.
Francesco Maria Iena et al.
Frontiers in endocrinology, 11, 577650-577650 (2020-11-17)
Obesity is associated with increased plasma glycerol levels. The coordinated regulation of glycerol channels in adipose tissue (AQP7) and the liver (AQP9) has been suggested as an important contributor to the pathophysiology of type-2-diabetes mellitus, as it would provide glycerol

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service